SIRA GROUP has completed its investment in Rosina Diagnostic Center in Nairobi, closing a nine-month process and taking a majority position in the facility.

Rosina opened in 2021 with MRI, CT and ultrasound and is the flagship centre of SIRA Healthcare. The investment funds the centre’s next phase — the PET-CT molecular imaging wing — and the roll-out of the group’s facility-management system, which schedules the modalities, tracks consumables and returns reports to referring clinicians in real time.

The transaction was structured through an Istanbul vehicle, with SIRA Consulting advising on the corridor, and is the first position in the group’s East African diagnostic network.